GBS® COATINGS

Clinical Data Support Cost Benefits of GBS

* Total hospital stay minus ICU stay

Table 6: Perioperative follow-up of patients with high risk. p<0.05 vs. control CPB: Cardiopulmonary bypass; X-clamp: Aortic cross clamp;
t-intub: respiratory support time; ICU: Intensive care unit; NYHA: New York Heart Association Class; EF: Ejection Fraction

**Cost data taken from Hannon HJ, Gjerde KP. The contemporary economics of transfusions. In: Spiess BD, Spence RK, Shandler eds.
Perioperative Transfusion Medicine. Philadelphis: Lippincott Williams & Wilkins, 2005:13-38

Studies, White Papers and Presentations
	Clinical Performance and Biocompatibility of Novel Hyaluronan-Based Heparin-Bonded Extracorporeal Circuits (216kb pdf)
	GISH Biomedical, Inc., a member of the MEDOS group, receives FDA clearance for GBS® – Heparin Free products (170kb pdf)
	Clinical Performance and Biocompatibility of Novel Hyaluronan-Coated Heparin Free Extracorporeal Circuits in High-risk Patients Undergoing Coronary Revascularization (2.2mb pdf)